Groth Shawn S, Whitson Bryan A, Kuskowski Michael A, Holmstrom Amy M, Rubins Jeffrey B, Kelly Rosemary F
Department of Surgery, 420 Delaware Street, S.E., University of Minnesota, Minneapolis, MN 55455, United States.
Lung Cancer. 2009 Jun;64(3):352-7. doi: 10.1016/j.lungcan.2008.09.015. Epub 2008 Nov 18.
There is a lack of evidence in the literature regarding the impact of preoperative smoking status on pulmonary function test (PFT) results 1 year after resection for non-small cell lung cancer (NSCLC). Furthermore, there is disagreement in the literature regarding the impact of preoperative smoking cessation on postoperative complication rates. We performed a single-institution retrospective review of all NSCLC patients who underwent resection from April 2000 through April 2006. Timing of smoking cessation was stratified as follows: smoking cessation more than a month before surgery (Distant Smokers), smoking cessation within a month before surgery (Recent Smokers), and failure to achieve smoking cessation before surgery (Current Smokers). During the study period, 213 patients underwent NSCLC resection, 121 of whom (all males; mean age, 67.4 years) completed pre- and postoperative PFTs. After adjusting for potential confounding covariates (age, type of resection, and use of radiation therapy), we noted no significant difference (p>0.40) between groups after resection with regard to either relative (-12.20+/-15.77L [Distant Smokers], -15.38+/-19.38L [Recent Smokers], -9.61+/-15.54L [Current Smokers]) or absolute changes in percent predicted forced expiratory volume in 1s (-0.14+/-0.20L [Distant Smokers], -0.18+/-0.19L [Recent Smokers], -0.12+/-0.20L [Current Smokers]). Because 92 patients did not complete postoperative PFTs, we performed a stratified analysis to assess for selection bias; as compared with those who completed PFTs, baseline PFT results did not significantly differ. We found no significant differences between the 3 groups with regard the overall rate of postoperative complications or the rate of any specific postoperative complication. In conclusion, smoking cessation immediately before NSCLC resection does not significantly impact postoperative pulmonary complication rates or 1-year postoperative PFT results and therefore should not be a reason to delay surgical resection.
关于术前吸烟状态对非小细胞肺癌(NSCLC)切除术后1年肺功能测试(PFT)结果的影响,文献中缺乏相关证据。此外,文献中对于术前戒烟对术后并发症发生率的影响也存在分歧。我们对2000年4月至2006年4月期间接受切除术的所有NSCLC患者进行了单机构回顾性研究。戒烟时间分层如下:术前一个多月戒烟者(远期吸烟者)、术前一个月内戒烟者(近期吸烟者)和术前未戒烟者(当前吸烟者)。在研究期间,213例患者接受了NSCLC切除术,其中121例(均为男性;平均年龄67.4岁)完成了术前和术后的PFT。在调整了潜在的混杂协变量(年龄、切除类型和放疗使用情况)后,我们发现切除术后各组之间在相对(-12.20±15.77L[远期吸烟者],-15.38±19.38L[近期吸烟者],-9.61±15.54L[当前吸烟者])或1秒用力呼气量预测百分比的绝对变化(-0.14±0.20L[远期吸烟者],-0.18±0.19L[近期吸烟者],-0.12±0.20L[当前吸烟者])方面均无显著差异(p>0.40)。由于92例患者未完成术后PFT,我们进行了分层分析以评估选择偏倚;与完成PFT的患者相比,基线PFT结果无显著差异。我们发现三组在术后总体并发症发生率或任何特定术后并发症发生率方面均无显著差异。总之,NSCLC切除术前立即戒烟对术后肺部并发症发生率或术后1年PFT结果无显著影响,因此不应成为延迟手术切除的理由。